SIVODAZOLE

This brand name is authorized in Nigeria.

Active ingredients

The drug SIVODAZOLE contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-8613	Chewable tablet	Sivodazole Tablets TAB_CHEW 400 mg		03/08/2021
A4-9055	Suspension	SIVODAZOLE SUSPENSION SUSP 200 mg/5 mL 1X1OML	SIVODAZOLE SUSPENSION ALBENDAZOLE ALBENDAZOLE 200MG/5ML A4-9055 Drugs Imported Products 1X1OML Prescription Only Medicine (POM) 12/10/2020 ADPHARM PHARMACETICAL INDUSTRIES LIMITED, BRIDGE HEAD INDUSTRIAL LAYOUT ONITSHA ANAMBRA 9082437677 adpharmaltd@yahoo.com RHYDBURG PHARMACEUTICALS LTD, C-2 & 3, S.I.E.L.SELAQUI, DEHRADUN, UTTARAKHAND, INDIA., India	26/04/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-8613, A4-9055